Acquisition method (AMC)
1
FSC 6505 × CEFAZOLIN INJECTION
CEFAZOLIN INJECTION
6505-01-480-2501 FSC 6505
NSN 6505-01-480-2501 (also written 6505014802501; NIIN 01-480-2501) is a cefazolin injection in Federal Supply Class 6505, Drugs and Biologicals. 5 manufacturer part numbers from 5 suppliers are on record. It was last purchased in Oct 2026.
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
This item is coded as suitable for competitive acquisition (AMC 1).
Suffix (AMSC)
Z
Competition
Coded for competition
AMC 1: suitable for competitive acquisition, second or later time. AMSC Z: a commercial, nondevelopmental or off-the-shelf item. The codes describe the item's status on record, not any one solicitation. What the codes mean
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH AKJA | GRAMS CEFAZOLIN ACTIVE INGREDIENT 1.000 |
| PRIMARY CONTAINER TYPE CQCT | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY CRLK | MILLILITERS 10.000 |
| TOTAL PRIMARY CONTAINER QUANTITY CSCW | 25 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | CEFAZOLIN FOR INJECTION, USP. 1 GRAM VIAL 25EA. |
| SPECIAL FEATURES FEAT | CEFAZOLIN FOR INJECTION, USP. 1 GRAM PER VIAL.FOR INTRAVENOUS OR INTRAMUSCULAR USE. PROTECT FROM LIGHT AND STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE). |
| MEDICAL DESIGNATION AND GRADE MDES | UNITED STATES PHARMACOPEIA |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| 00-0714 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
| NDC00143-9924-90 | 32655 | HIKMA PHARMACEUTICALS USA INC. |
| NDC00781345196 | 0THL4 | SANDOZ INC. |
| NDC44567-0707-25 | 6XJQ8 | WG CRITICAL CARE, LLC |
| NDC63323-0237-10 | 1DQP2 | AMERICAN PHARMACEUTICAL PARTNERS |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Latest unit price
—
Purchases
0
Total spend
—
Oct 16, 2026
Last purchased
10 · 10.0/yr
Purchase records
$1,658
Total demand
$36.10
Latest award total
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
| Action date | Award # | Recipient | Agency | Obligation |
|---|---|---|---|---|
| Sep 18, 2026 | SPE2DX25D9900/SPE2DP26F003J ↗ | DMS PHARMACEUTICAL GROUP INC | — | $722.00 |
| Sep 22, 2026 | SPE2DX25D9900/SPE2DP26F005N ↗ | DMS PHARMACEUTICAL GROUP INC | — | $72.20 |
| Sep 24, 2026 | SPE2DX25D9900/SPE2DP26F010R ↗ | DMS PHARMACEUTICAL GROUP INC | — | $36.10 |
| Sep 25, 2026 | SPE2DX25D9900/SPE2DP26F016R ↗ | DMS PHARMACEUTICAL GROUP INC | — | $36.10 |
| Sep 28, 2026 | SPE2DX25D9900/SPE2DP26F021N ↗ | DMS PHARMACEUTICAL GROUP INC | — | $36.10 |
| Sep 28, 2026 | SPE2DX25D9900/SPE2DP26F022M ↗ | DMS PHARMACEUTICAL GROUP INC | — | $72.20 |
| Sep 28, 2026 | SPE2DX25D9900/SPE2DP26F022S ↗ | DMS PHARMACEUTICAL GROUP INC | — | $144.40 |
| Sep 29, 2026 | SPE2DX25D9900/SPE2DP26F028T ↗ | DMS PHARMACEUTICAL GROUP INC | — | $216.60 |
| Oct 8, 2026 | SPE2DX25D8022/SPE2D927F0055 ↗ | CARDINAL HEALTH, INC. | — | $286.56 |
| Oct 16, 2026 | SPE2DX25D9900/SPE2DP27F0213 ↗ | DMS PHARMACEUTICAL GROUP INC | — | $36.10 |
Demand history
Every solicitation we've indexed for this NSN, open and closed — 1 on record. Closed RFQs (expired, cancelled, or awarded) stay here as a record of past demand; they never get removed.
Who wins this item
Does one supplier win this every time, and are the winners on the listed-source list? One dot per award.
- Award in the last 2 years
- Older award
DMS PHARMACEUTICAL GROUP INC
last award Oct 2026
CARDINAL HEALTH, INC.
last award Oct 2026
AMERICAN PHARMACEUTICAL PARTNERS
no award yet
no awards on record
Listed source DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
no award yet
no awards on record
Listed source HIKMA PHARMACEUTICALS USA INC.
no award yet
no awards on record
Listed source SANDOZ INC.
no award yet
no awards on record
Listed source WG CRITICAL CARE, LLC
no award yet
no awards on record
Listed source DMS PHARMACEUTICAL GROUP INC won 9 of the last 10 awards. DMS PHARMACEUTICAL GROUP INC and 1 other won without being listed sources.
| Solicitation | Issued | Closes / closed | Qty | Status | |
|---|---|---|---|---|---|
| SPE2DP-26-T-4941 | Sep 9, 2026 | Sep 14, 2026 | 1 | Expired | View at DIBBS → |
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history as of Oct 10, 2026.
- Contract action totals: USAspending, context only.
- Data last refreshed: 2026-10-17.
- Full methodology →
Cite this page
Citation
NSN Explorer. "CEFAZOLIN INJECTION." nsnexplorer.com, https://nsnexplorer.com/nsn/6505-01-480-2501/. Data as of October 19, 2026.
Link
https://nsnexplorer.com/nsn/6505-01-480-2501/